United Therapeutics Co. (NASDAQ:UTHR) Position Increased by LSV Asset Management

LSV Asset Management raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 383,068 shares of the biotechnology company’s stock after acquiring an additional 3,700 shares during the […]

Related Keywords

United States ,Blackrock ,New Zealand General ,New Zealand ,Wellington ,Paula Mahon ,Christopher Causey ,United Therapeutics Company Profile ,Morgan Stanley ,Exchange Commission ,Blackrock Inc ,Wells Fargo Company ,United Therapeutics Co ,Nasdaq ,Jpmorgan Chase Co ,United Therapeutics Corporation ,Wellington Management Group ,Geode Capital Management ,United Therapeutics ,Free Report ,Street Corp ,Management Group ,Capital Management ,Palo Alto Investors ,Alto Investors ,Get Free Report ,Director Christopher Causey ,Therapeutics Corporation ,Remunity Pump ,United Therapeutics Daily ,Nasdaq Uthr ,Suthr ,Medical ,91307c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,